🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550
Whole Brain Radiation Therapy (WBRT) has long been the mainstay of treatmen...
Status
Completed
Location
Gamma Knife Center Tilburg, Elisabeth-TweeSteden Hospital
Start Date
2016-02
Trial ID
NCT02953717
Treatments Being Tested
The goal of this observational study is to learn about treatments in brain ...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-12-15
Trial ID
NCT05609162
Treatments Being Tested
This study is designed to see if we can lower the chance of side effects fr...
Status
Active Not Recruiting
Location
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Start Date
2023-07-11
Trial ID
NCT05703269
This phase I/II trial studies the side effects and best dose of nivolumab w...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-12-16
Trial ID
NCT02696993
The purpose of this trial is to test the safety and tolerance of the combin...
Status
Terminated
Location
Neurologische Universitaetsklinik Bonn
Start Date
2012-03
Trial ID
NCT01563614
The investigators seek to perform an observational study in patients with b...
Status
Unknown
Location
Thomas Jefferson University Hospital
Start Date
2013-03
Trial ID
NCT01861405
This is randomized study of neurocognitive outcomes in patients with five o...
Status
Withdrawn
Location
University of California, San Francisco
Start Date
2012-12
Trial ID
NCT01731704
Treatments Being Tested
The aim of the study is to generate patient-derived organoids (PDOs) from b...
Status
Recruiting
Location
Guy's and St. Thomas NHS Foundation Trust
Start Date
2025-05-27
Trial ID
NCT06468124
This phase I trial studies the side effects and best dose of ipilimumab whe...
Status
Completed
Location
Ohio State University
Start Date
2012-11-09
Trial ID
NCT01703507
Treatments Being Tested